GT Biopharma, Inc.

New Filing
CIK: 0000109657·Biotechnology·FLORIDA·Filed: Aug 17, 2018
Total Offering

$5,140,000

Amount Sold

$5,140,000

Investors

13

First Sale

Aug 2, 2018

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Steven Weldon
Related Person
Anthony J. Cataldo
Related Person
Kathleen Clarence-Smith
Related Person
Geoffrey B. Davis
Related Person
Peter Kiener
Related Person
Jon Bonfiglio
Related Person
Raymond Urbanski
Related Person

Company

GT Biopharma, Inc.

100 SOUTH ASHLEY DRIVE

TAMPA, FL, 33602

800-304-9888

SEC Filing

0001654954-18-009332

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free